Michael Kinch
Michael Kinch is Associate Vice Chancellor and Director, Centre for Research Innovation in Business at Washington University in St Louis, US.
False
Advertisement
A Dangerous Trend?
December 17, 2015
The reverse merger between Pfizer and Allergan is the most recent chapter in a decades-long transformation of the pharma industry, but I believe it also represents a rapid acceleration of a troubling trend.
1 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
